Literature DB >> 26418885

Assessment of ICD-9-based case definitions for influenza-like illness surveillance.

Angelia A Eick-Cost, Devin J Hunt.   

Abstract

Population-based surveillance of influenza routinely relies on administrative medical encounter databases and ICD-9 codes. However, an assessment of the ICD-9 codes used for the Department of Defense (DoD) influenza-like illness (ILI) case definition has not been conducted since 2007. As coding practices may have changed over time, this analysis was done to determine the sensitivity, specificity, and positive predictive value (PPV) of the current ILI case definition and three alternative case definitions for the 2014-2015 influenza season. Influenza laboratory tests conducted on specimens from DoD beneficiaries during the 2014-2015 season were matched to ambulatory and inpatient medical encounters. The current DoD ILI case definition had high sensitivity (92%) but low specificity (30%) and moderate PPV (63%). A more specific ILI case definition utilizing only codes with greater than 75% influenza positivity for the matched laboratory test had high specificity (96%) and PPV (96%) and moderate sensitivity (62%). The current ILI case definition is sufficient for broad, sensitive population-based surveillance; however, an alternative case definition may be more appropriate when there is a need to maximize specificity.

Mesh:

Year:  2015        PMID: 26418885

Source DB:  PubMed          Journal:  MSMR        ISSN: 2152-8217


  9 in total

1.  Novel Use of Flu Surveillance Data: Evaluating Potential of Sentinel Populations for Early Detection of Influenza Outbreaks.

Authors:  Ashlynn R Daughton; Nileena Velappan; Esteban Abeyta; Reid Priedhorsky; Alina Deshpande
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

2.  An extensible framework and database of infectious disease for biosurveillance.

Authors:  Ashlynn R Daughton; Reid Priedhorsky; Geoffrey Fairchild; Nicholas Generous; Andrea Hengartner; Esteban Abeyta; Nileena Velappan; Antonietta Lillo; Karen Stark; Alina Deshpande
Journal:  BMC Infect Dis       Date:  2017-08-07       Impact factor: 3.090

3.  Influenza-like illness as a trigger for ischemic stroke.

Authors:  Amelia K Boehme; Jorge Luna; Erin R Kulick; Hooman Kamel; Mitchell S V Elkind
Journal:  Ann Clin Transl Neurol       Date:  2018-03-14       Impact factor: 4.511

4.  Inpatient hospital fatality related to coding (ICD-9-CM) of the influenza diagnosis in Spain (2009-2015).

Authors:  J M San-Román-Montero; R Gil Prieto; C Gallardo Pino; J Hinojosa Mena; A Zapatero Gaviria; A Gil de Miguel
Journal:  BMC Infect Dis       Date:  2019-08-07       Impact factor: 3.090

5.  Risk of stroke and myocardial infarction after influenza-like illness in New York State.

Authors:  Erin R Kulick; Trevor Alvord; Michelle Canning; Mitchell S V Elkind; Bernard P Chang; Amelia K Boehme
Journal:  BMC Public Health       Date:  2021-05-05       Impact factor: 3.295

6.  Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States.

Authors:  Constantina Boikos; Lauren Fischer; Dan O'Brien; Joe Vasey; Gregg C Sylvester; James A Mansi
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

7.  The Impact of the COVID-19 Pandemic on Respiratory Illness Admissions at a Single Academic Institution in Arkansas.

Authors:  Mallory Heft; Joshua Mueller; Hanna Jensen; Nicholas Kaukis; Mollie Meek
Journal:  Int J Environ Res Public Health       Date:  2022-10-01       Impact factor: 4.614

8.  Comparison of influenza surveillance data from the Republic of Korea, selected northern hemisphere countries and 
Hong Kong Special Administrative Region SAR (China) from 2012 to 2017.

Authors:  Bryan Inho Kim; Ok Park; Sangwon Lee
Journal:  Western Pac Surveill Response J       Date:  2020-09-30

9.  Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season.

Authors:  Constantina Boikos; Mahrukh Imran; Van Hung Nguyen; Thierry Ducruet; Gregg C Sylvester; James A Mansi
Journal:  Open Forum Infect Dis       Date:  2021-04-02       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.